SMS Pharmaceuticals Limited — Important, 25-06-2025: General Updates
25-06-2025 | 04:10 pm
25-06-2025 | 04:10 pm
SMS Pharmaceuticals has announced a board meeting to review the financial results for the quarter and half-year. The company successfully completed its second USFDA inspection at the Central Laboratory Analytical Services facility in Hyderabad with zero Form 483 observations, reflecting strong compliance and quality standards. This reinforces SMS Pharma’s commitment to regulatory excellence, potentially enhancing investor confidence in its manufacturing and analytical capabilities.
No comments yet. Be the first to comment!
